Given as few as six times per year and demonstrated superior efficacy to a daily oral PrEP option (FTC/TDF tablets) in reducing the risk of HIV acquisition
Initiation of EBT-101 Phase 1/2 clinical trial expected later this year
Laurus will be incentivised for a portion of its development and commercialisation costs. CHAI will also provide technical and regulatory support to enable accelerated generic development
The group, known as the HIV Obstruction by Programmed Epigenetics (HOPE) Collaboratory, will be led by researchers at Gladstone Institutes, Scripps Research Florida, and Weill Cornell Medicine. Their approach, which aims to both silence and permanently remove HIV from the body, takes advantage of knowledge about how other viruses have become naturally inactivated over time.
Emtricitabine and Tenofovir Disoproxil Fumarate tablets had estimated annual sales of US $2.1 billion in the U.S. according to IQVIA MAT March 2021
But acquisition charges drag earnings into loss
The summit brought together over 150 doctors, researchers, and practitioners worldwide
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
4th World Homoeopathy Summit at Palace of Westminster and University of Oxford spotlights integrative healthcare and global collaboration
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
Subscribe To Our Newsletter & Stay Updated
